Difference between revisions of "Team:UCL/Human Practices"

 
(148 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
{{UCL/TemplateBefore}}
 
{{UCL/TemplateBefore}}
 +
 
<html>
 
<html>
 
<body>
 
<body>
−
<main class="cd-main-content">
+
−
     <div id="main-content-container">
+
<style>
 +
.fixed-bg {
 +
    background-image: url("https://static.igem.org/mediawiki/2016/9/98/T--UCL--backgroundhp.png");
 +
     min-height: 500px;
 +
    background-attachment: fixed;
 +
    background-position: center;
 +
    background-repeat: no-repeat;
 +
    background-size: cover;
 +
}
 +
</style>
  
−
<h2 align="center"> <font size="30"> <b>  OUR STORY </b> </font> </h2>
+
<div class="fixed-bg">  
−
<br>
+
<div style="height: 400px;"> </div>
  
−
<h3> <center> We are all stakeholders in ageing hence why Biosynthage has been steeped in controversy since its very inception. However, with controversy comes important questions. Some believe that we should not meddle with the human ageing process and others believe that we should think of ageing as a disease in order to start treating it. Biosynthage has really enjoyed exploring the depths of many debates which has caused us to constantly stop and reevaluate the next step forward within our project. We are constantly realising that with every new person we speak to, we uncover depths of new perspectives we never knew existed within in our story.</center> </h3>
+
<head>
−
                      <br>
+
 
−
                      <br>
+
 
−
<h3> <center> In the following sections, you can have a glimpse at the decisive factors that drove our project and continue to influence the progress of our novel technologies in the future. Below is a timeline of events and activities that the UCL iGEM team were doing this summer! We have details of each event in our human practices silver page! </center> </h3>
+
            <div class="team10cover">
−
                      <br>
+
<h1> <center> <font size = "2000px" > <font color = "white" > OUR STORY </font> </font> </center> </h1>  
−
           
+
<h3> <center> <font color = "white" >  </font> </center> </h3>
 +
 
 +
</div>
 +
<br>
 
<br>
 
<br>
  
−
<div style="position: relative; top:966px; float: left;  width: 30%; padding: 0 20px 20px 30px;  text-align: right"> <a href="https://2016.igem.org/Team:UCL/HP/Silver/Public_Engagement"> <b> International survey: Exploring the global perception of ageing and synthetic biology </b> </a> </div>
 
  
  
−
<div style="position: relative; top:1300px; float: right;  width: 30%; padding: 0 20px 20px 30px;  text-align: left"> <a href="https://2016.igem.org/Team:UCL/HP/Silver/Experts"> <b> Discussing the foundations of our project with Aubrey de Grey </b> </a> </div> 
+
</head>
−
+
−
<div style="position: relative; top:1310px; float: left;  width: 30%; padding: 0 20px 20px 30px;  text-align: right"> <a href="https://2016.igem.org/Team:UCL/HP/Silver/Education"> <b> 3 day iGEM workshop for year 8 students </b> </a> </div>
+
−
+
  
−
<img src = "https://static.igem.org/mediawiki/2016/a/a4/T--UCL--coverimage1.png">
 
−
<img src = "https://static.igem.org/mediawiki/2016/4/43/T--UCL--coverimage2.png">
 
−
<img src = "https://static.igem.org/mediawiki/2016/f/ff/T--UCL--coverimage3.png">
 
−
</div>
 
  
−
<style>
 
−
.timeline-panel {
 
−
    border: 1px solid black;
 
−
    margin-top: 100px;
 
−
    margin-bottom: 100px;
 
−
    margin-right: 150px;
 
−
    margin-left: 80px;
 
−
    background-color: lightblue;
 
−
}
 
  
−
.timeline-panel1 {
+
<main class="cd-main-content">
−
    border: 1px solid black;
+
     <div id="main-content-container">
−
    margin-top: 100px;
+
<center> <img src = "https://static.igem.org/mediawiki/2016/6/63/T--UCL--swirl.png" width="190" height="90"  style="margin-Top:-150px" > </center>
−
     margin-bottom: 100px;
+
 
−
    margin-right: 150px;
+
 
−
    margin-left: 80px;
+
 
−
    background-color: lightblue;
+
 
−
}
+
 
−
</style>
+
<h3> <center> We are all stakeholders in ageing hence why Biosynthage has been steeped in controversy since its very inception. However, with controversy come important questions. Some believe that we should not meddle with the human ageing process whereas others believe that we should think of ageing as a disease in order to start treating it. Biosynthage has really enjoyed exploring the depths of many debates which has caused us to constantly stop and reevaluate the next step forward within our project. We are constantly realising that with every new person we speak to, we uncover depths of new perspectives we never knew existed within in our story.</center> </h3>
 +
                      <br>
 +
                      <br>
 +
<h3> <center> In the following sections, you can have a glimpse at the decisive factors that drove our project and continue to influence the progress of our novel technologies in the future. Below is a timeline of events and activities that the UCL iGEM team were doing this summer! We have details of each event in our human practices <a href="https://2016.igem.org/Team:UCL/HP/Silver"> silver </a> page! </center> </h3>
 +
 
 +
<br>
 +
<br>
 +
<h3> <center> Click <a href="https://2016.igem.org/Team:UCL/HP/Silver/Conclusion"> here </a> to find the conclusion of our story so far.  </center> </h3>          <br>           
 +
<br>
 +
<br>
 +
 
 +
<img src = "https://static.igem.org/mediawiki/2016/0/00/T--UCL--timelin1.png" >
  
−
<div class = "timeline-panel">This div element has a top margin of 100px, a right margin of 150px, a bottom margin of 100px, and a left margin of 80px.</div>
+
<img src = "https://static.igem.org/mediawiki/2016/e/e0/T--UCL--timeline2.png" >
  
−
<div class = "timeline-panel1">This div element has a top margin of 100px, a right margin of 150px, a bottom margin of 100px, and a left margin of 80px.</div>
+
<img src = "https://static.igem.org/mediawiki/2016/4/46/T--UCL--app929.png" >
  
  
  
 +
</div></div>
 
</main>
 
</main>
 
</body>
 
</body>
 
</html>
 
</html>
 
{{UCL/TemplateAfter}}
 
{{UCL/TemplateAfter}}

Latest revision as of 02:27, 20 October 2016

<!DOCTYPE html>

UCL iGEM 2016 | BioSynthAge

OUR STORY



We are all stakeholders in ageing hence why Biosynthage has been steeped in controversy since its very inception. However, with controversy come important questions. Some believe that we should not meddle with the human ageing process whereas others believe that we should think of ageing as a disease in order to start treating it. Biosynthage has really enjoyed exploring the depths of many debates which has caused us to constantly stop and reevaluate the next step forward within our project. We are constantly realising that with every new person we speak to, we uncover depths of new perspectives we never knew existed within in our story.



In the following sections, you can have a glimpse at the decisive factors that drove our project and continue to influence the progress of our novel technologies in the future. Below is a timeline of events and activities that the UCL iGEM team were doing this summer! We have details of each event in our human practices silver page!



Click here to find the conclusion of our story so far.